Invesco India Mid Cap Fund
The scheme seeks to generate capital appreciation by investing predominantly in Mid cap entities.
Growthvine rating: 4/5 — ranked #5 of 34 in category.
Fund basics
| Category | Equity: Mid Cap |
|---|
| NAV | ₹202.73 (as of 2026-11-13) |
|---|
| AUM | ₹15,832 Cr |
|---|
| Expense ratio | 1.44% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Aditya Khemani |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 15.89% |
|---|
| Sharpe ratio | 0.75 |
|---|
| Standard deviation | 20.15% |
|---|
| Max drawdown | −70.84% |
|---|
| Alpha | 6.04 |
|---|
| Beta | 1.04 |
|---|
Over 5 years, captured 104.5% of NIFTY Midcap 150's upside and 97.0% of its downside.
Market cap allocation
| Large cap | 15.9% |
|---|
| Mid cap | 61.0% |
|---|
| Small cap | 23.1% |
|---|
Concentration
| Top 5 holdings | 31.3% |
|---|
| Top 10 holdings | 51.0% |
|---|
| Total holdings | 41 |
|---|
| Index overlap | 17.9% |
|---|
| Active share | 82.1% |
|---|
Top holdings
- Max Healthcare Institute Limited — 7.9%
- Prestige Estates Projects Limited — 7.7%
- Federal Bank Ltd. — 6.1%
- Meesho Limited — 5.3%
- Eternal Limited — 4.4%
- Manipal Health Enterprises Limited — 4.2%
- L&T Finance Limited — 4.2%
- AU Small Finance Bank Limited — 4.0%
- Sai Life Sciences Limited — 3.7%
- Global Health Limited — 3.7%
Top sectors
- Retail — 24.0%
- Banking & Financial — 17.4%
- Healthcare — 17.3%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 10.5% | Q1 (Top) | #4 of 31 |
| 2025 | 6.3% | Q1 (Top) | #4 of 29 |
| 2024 | 43.1% | Q1 (Top) | #2 of 29 |
| 2023 | 34.1% | Q3 | #20 of 28 |
| 2022 | 0.5% | Q3 | #15 of 22 |